Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
In: American Journal of Roentgenology, Jg. 214 (2020-02-01), S. 324-327
Online
unknown
Zugriff:
OBJECTIVE. The purpose of this article is to describe the risk-benefit balance of contrast-enhanced breast MRI (CE-BMRI) screening. CONCLUSION. CE-BMRI confers risk of effects associated with administration of gadolinium-based contrast agents (GBCAs), including nephrogenic systemic fibrosis and gadolinium retention. The risk-benefit balance of CE-BMRI screening is favorable for carriers of BRCA, TP53, or other deleterious mutations women who have undergone thoracic irradiation; and women at 20% or greater lifetime risk of breast cancer. The balance is uncertain, however, for women at intermediate to average risk. Women must always receive detailed information regarding possible GBCA-associated effects.
Titel: |
Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
|
---|---|
Autor/in / Beteiligte Person: | Trimboli, Rubina M. ; Schiaffino, Simone ; Cozzi, Andrea ; Sardanelli, Francesco |
Link: | |
Zeitschrift: | American Journal of Roentgenology, Jg. 214 (2020-02-01), S. 324-327 |
Veröffentlichung: | American Roentgen Ray Society, 2020 |
Medientyp: | unknown |
ISSN: | 1546-3141 (print) ; 0361-803X (print) |
DOI: | 10.2214/ajr.19.21988 |
Schlagwort: |
|
Sonstiges: |
|